---
title: "Theravance facing several lawsuits seeking to block Zymeworks acquisition"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298616753.md"
description: "Theravance facing several lawsuits seeking to block Zymeworks acquisition"
datetime: "2026-09-10T15:15:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298616753.md)
  - [en](https://longbridge.com/en/news/298616753.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298616753.md)
generator: "portal-rs"
---

# Theravance facing several lawsuits seeking to block Zymeworks acquisition


### Related Stocks

- [ZYME.US](https://longbridge.com/en/quote/ZYME.US.md)
- [TBPH.US](https://longbridge.com/en/quote/TBPH.US.md)

## Related News & Research

- [Roche Collaboration and Royalty-Focused Model Drive Higher Zymeworks Valuation, Supporting Buy Rating](https://longbridge.com/en/news/302918616.md)
- [Zymeworks Highlights ZW191 Ovarian Cancer Responses, Roche Deal Upside](https://longbridge.com/en/news/303296613.md)
- [Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal](https://longbridge.com/en/news/302858468.md)
- [Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal](https://longbridge.com/en/news/300333672.md)
- [ZYME: Acquisition expands portfolio and revenue streams, with integration completed September 2026](https://longbridge.com/en/news/300285352.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**